Preventive Central-Nervous-System Therapy in Acute Leukemia
- 6 December 1973
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 289 (23) , 1248-1249
- https://doi.org/10.1056/nejm197312062892312
Abstract
Because acute leukemia, unlike other forms of cancer, is disseminated at the time of diagnosis, systemic chemotherapy has been the cornerstone of treatment. The increasingly skillful use of effective drugs improved the frequency and duration of remission especially in children with acute lymphocytic leukemia (ALL). Better control of systemic leukemia and longer survival were accompanied, however, by the increased frequency of Central-nervous-system (CNS) (meningeal) involvement. Treatment with intrathecal chemotherapy, irradiation or both was only palliative. Recurrence with its attendant complications was distressingly common.In 1962 the group at St. Jude Children's Research Hospital in Memphis began a series of studies . . .Keywords
This publication has 6 references indexed in Scilit:
- Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal LeukemiaNew England Journal of Medicine, 1973
- Encephalopathy Following CNS Prophylaxis in Childhood Lymphoblastic LeukemiaPediatrics, 1973
- Comparison of Two Methods of Preventing Central Nervous System LeukemiaBlood, 1973
- Prevention of central nervous system leukemia by irradiationCancer, 1973
- Encephalopathy in Acute Leukaemia Associated with Methotrexate TherapyArchives of Disease in Childhood, 1972